Related Experiment Video
Updated: May 23, 2026
10:46
Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
Published on: May 2, 2016
2011 Rita Schaffer lecture: nanoparticles for intracellular nucleic acid delivery
1Department of Biomedical Engineering, The Wilmer Eye Institute, The Institute for Nanobiotechnology, and The Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, 400 N Broadway, Smith 5017, Baltimore, MD 21231, USA. green@jhu.edu
Annals of Biomedical Engineering
|March 28, 2012
Summary
Polymeric nanoparticles effectively deliver DNA and siRNA therapeutics into human cells. Biomaterial structure, including degradable linkages, dictates delivery success and cell-type specificity for gene therapy applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Polymeric nanoparticles offer a promising platform for novel therapeutic delivery.
- A polymer library approach has enabled the engineering of particles optimized for DNA and siRNA delivery to human cells.
- Key factors for successful intracellular delivery include specific chemical motifs, degradable linkages, hydrophobicity, and biophysical properties.
Discussion:
- Subtle modifications in polymer structure, particularly degradable linkages, significantly impact the efficacy of siRNA versus DNA delivery.
- Tailoring biomaterial composition can achieve cell-type specific gene delivery, distinguishing between human brain cancer cells and healthy cells, or retinal endothelial cells and epithelial cells.
- These engineered nanoparticles demonstrate broad applicability across various human cell types.
Key Insights:
- Polymeric nanoparticles are engineered for efficient nucleic acid delivery.
- Degradable linkages and hydrophobicity are critical for intracellular delivery success.
- Biomaterial structure dictates specificity for gene delivery in targeted cell types.
Outlook:
- Applications in regenerative medicine, ophthalmology, and oncology.
- Potential for developing targeted gene therapies with enhanced safety and efficacy.
- Further research into nanoparticle-biomaterial interactions for optimized therapeutic delivery.
